资讯

来自MSN1 个月
Scientists propose CDK2 enzyme as new target for cancer therapy
FDA-approved CDK4/6 inhibitors include abemaciclib (brand name Verzenio), ribociclib (brand name Kisqali ... "By leveraging cell cycle biomarkers, we hope to be able to identify patients that ...